Joint Replenishment Problem on JRP (test)
0.01Std DevPPO
Evaluation results
| Method | Links | |||||
|---|---|---|---|---|---|---|
| PPOProduct count (p)=20, Batch size (B)=64, Number of independent trials=102026.05 | 0.01 | — | — | 38.85 | 38.86 | |
| HPOFullProduct count (p)=1, Batch size (B)=64, Number of independent trials=102026.05 | 0.02 | — | — | 34.94 | 34.93 | |
| PPOProduct count (p)=1, Batch size (B)=64, Number of independent trials=102026.05 | 0.02 | — | — | 34.93 | 34.94 | |
| PPOProduct count (p)=5, Batch size (B)=64, Number of independent trials=102026.05 | 0.02 | — | — | 38.45 | 38.45 | |
| PPOProduct count (p)=10, Batch size (B)=64, Number of independent trials=102026.05 | 0.02 | — | — | 38.52 | 38.52 | |
| PPOProduct count (p)=40, Batch size (B)=64, Number of independent trials=102026.05 | 0.02 | — | — | 38.8 | 38.8 | |
| PPOproduct count (p)=1, batch size (B)=16, independent trials=102026.05 | 0.03 | 34.94 | 34.93 | — | — | |
| HPONoCrossProduct count (p)=1, Batch size (B)=64, Number of independent trials=102026.05 | 0.03 | — | — | 34.95 | 34.96 | |
| PPOProduct count (p)=3, Batch size (B)=64, Number of independent trials=102026.05 | 0.03 | — | — | 37.09 | 37.09 | |
| PPOProduct count (p)=30, Batch size (B)=64, Number of independent trials=102026.05 | 0.03 | — | — | 38.51 | 38.5 | |
| HPOFullproduct count (p)=1, batch size (B)=16, independent trials=102026.05 | 0.04 | 34.96 | 34.97 | — | — | |
| HPOFullProduct count (p)=3, Batch size (B)=64, Number of independent trials=102026.05 | 0.04 | — | — | 37.09 | 37.1 | |
| HPONoCrossProduct count (p)=3, Batch size (B)=64, Number of independent trials=102026.05 | 0.04 | — | — | 37.11 | 37.1 | |
| HPOFullProduct count (p)=10, Batch size (B)=64, Number of independent trials=102026.05 | 0.04 | — | — | 38.6 | 38.61 | |
| HPOFullProduct count (p)=20, Batch size (B)=64, Number of independent trials=102026.05 | 0.04 | — | — | 38.83 | 38.82 | |
| HPONoCrossproduct count (p)=1, batch size (B)=16, independent trials=102026.05 | 0.05 | 34.97 | 34.95 | — | — | |
| PPOproduct count (p)=5, batch size (B)=16, independent trials=102026.05 | 0.05 | 38.56 | 38.56 | — | — | |
| PPOproduct count (p)=3, batch size (B)=16, independent trials=102026.05 | 0.06 | 37.18 | 37.2 | — | — | |
| HPONoCrossProduct count (p)=5, Batch size (B)=64, Number of independent trials=102026.05 | 0.06 | — | — | 38.54 | 38.55 | |
| HPOFullProduct count (p)=30, Batch size (B)=64, Number of independent trials=102026.05 | 0.06 | — | — | 38.46 | 38.44 | |
| HPONoCrossproduct count (p)=3, batch size (B)=16, independent trials=102026.05 | 0.07 | 37.27 | 37.29 | — | — | |
| PPOproduct count (p)=10, batch size (B)=16, independent trials=102026.05 | 0.07 | 38.68 | 38.67 | — | — | |
| HPOFullproduct count (p)=3, batch size (B)=16, independent trials=102026.05 | 0.08 | 37.24 | 37.21 | — | — | |
| PPOproduct count (p)=20, batch size (B)=16, independent trials=102026.05 | 0.08 | 39.23 | 39.22 | — | — | |
| HPOFullProduct count (p)=5, Batch size (B)=64, Number of independent trials=102026.05 | 0.08 | — | — | 38.56 | 38.58 | |
| HPOFullproduct count (p)=10, batch size (B)=16, independent trials=102026.05 | 0.1 | 38.79 | 38.83 | — | — | |
| HPOFullproduct count (p)=5, batch size (B)=16, independent trials=102026.05 | 0.12 | 38.82 | 38.8 | — | — | |
| HPOFullproduct count (p)=20, batch size (B)=16, independent trials=102026.05 | 0.12 | 39.08 | 39.09 | — | — | |
| HPONoCrossProduct count (p)=10, Batch size (B)=64, Number of independent trials=102026.05 | 0.14 | — | — | 38.7 | 38.68 | |
| HPONoCrossproduct count (p)=5, batch size (B)=16, independent trials=102026.05 | 0.16 | 38.77 | 38.76 | — | — | |
| HPONoCrossproduct count (p)=10, batch size (B)=16, independent trials=102026.05 | 0.16 | 38.85 | 38.86 | — | — | |
| HPONoCrossproduct count (p)=20, batch size (B)=16, independent trials=102026.05 | 0.16 | 39.26 | 39.24 | — | — | |
| HPONoCrossproduct count (p)=30, batch size (B)=16, independent trials=102026.05 | 0.27 | 39.54 | 39.53 | — | — | |
| HPOFullProduct count (p)=40, Batch size (B)=64, Number of independent trials=102026.05 | 0.29 | — | — | 38.87 | 38.76 | |
| HPONoCrossProduct count (p)=20, Batch size (B)=64, Number of independent trials=102026.05 | 0.33 | — | — | 38.98 | 38.87 | |
| HPONoCrossProduct count (p)=30, Batch size (B)=64, Number of independent trials=102026.05 | 0.33 | — | — | 38.81 | 38.72 | |
| HPOFullproduct count (p)=30, batch size (B)=16, independent trials=102026.05 | 0.38 | 39.43 | 39.33 | — | — | |
| HPONoCrossproduct count (p)=40, batch size (B)=16, independent trials=102026.05 | 0.49 | 40.82 | 40.98 | — | — | |
| HPONoCrossProduct count (p)=50, Batch size (B)=64, Number of independent trials=102026.05 | 0.5 | — | — | 40.1 | 40 | |
| HPONoCrossProduct count (p)=40, Batch size (B)=64, Number of independent trials=102026.05 | 0.55 | — | — | 39.66 | 39.46 | |
| HPOFullProduct count (p)=50, Batch size (B)=64, Number of independent trials=102026.05 | 0.71 | — | — | 39.66 | 39.97 | |
| HPOFullproduct count (p)=40, batch size (B)=16, independent trials=102026.05 | 0.72 | 40.4 | 40.28 | — | — | |
| HPOFullProduct count (p)=60, Batch size (B)=64, Number of independent trials=102026.05 | 0.98 | — | — | 40.7 | 40.34 | |
| HPONoCrossproduct count (p)=50, batch size (B)=16, independent trials=102026.05 | 1.43 | 42.95 | 42.44 | — | — | |
| PPOProduct count (p)=60, Batch size (B)=64, Number of independent trials=102026.05 | 1.62 | — | — | 59.18 | 59.09 | |
| HPONoCrossproduct count (p)=60, batch size (B)=16, independent trials=102026.05 | 1.75 | 49.92 | 50.39 | — | — | |
| PPOproduct count (p)=40, batch size (B)=16, independent trials=102026.05 | 1.92 | 70.37 | 69.73 | — | — | |
| HPOFullproduct count (p)=50, batch size (B)=16, independent trials=102026.05 | 2.19 | 43.47 | 42.77 | — | — | |
| PPOProduct count (p)=50, Batch size (B)=64, Number of independent trials=102026.05 | 2.2 | — | — | 48.75 | 48.89 | |
| PPOproduct count (p)=60, batch size (B)=16, independent trials=102026.05 | 2.76 | 89.29 | 88.59 | — | — | |
| PPOproduct count (p)=30, batch size (B)=16, independent trials=102026.05 | 2.87 | 51.67 | 51.85 | — | — | |
| HPOFullproduct count (p)=60, batch size (B)=16, independent trials=102026.05 | 3.12 | 50.28 | 49.71 | — | — | |
| HPONoCrossProduct count (p)=60, Batch size (B)=64, Number of independent trials=102026.05 | 3.17 | — | — | 43.37 | 41.94 | |
| PPOproduct count (p)=50, batch size (B)=16, independent trials=102026.05 | 3.27 | 81.36 | 80.18 | — | — |